Assessment of family history using genogram
Related entities
Findings (27)
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD
None
improvementAmong clinical features (as opposed to imaging or lab tests), absence of any family history of coronary heart disease was the strongest negative risk marker, providing moderate downgrading of CHD and
Effect: improvement; DLR 0.76 (SD 0.07) for all CHD; DLR 0.81 (SD 0.06) for CVD